ArticlePreventive medicine reports2020

Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada.

Rodica Gilca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.